These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 13226853)

  • 1. [Biochemical and biologic considerations on fibronolysis].
    KOWALSKI E
    Wiad Lek Wars Pol 1948; 1954 Feb; 7(2):81-8. PubMed ID: 13226853
    [No Abstract]   [Full Text] [Related]  

  • 2. Some biologic considerations in the treatment of breast carcinoma.
    BLACK MM; SPEER FD
    N Y State J Med; 1952 Mar; 52(5):569-71. PubMed ID: 14899720
    [No Abstract]   [Full Text] [Related]  

  • 3. [GENERAL BIOLOGIC CONSIDERATIONS ON TRANSPORT AND UTILIZATION OF OXYGEN IN LIVING ORGANISMS].
    FRANGINI G
    Osp Ital Chir; 1965 Feb; 12():133-43. PubMed ID: 14310509
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen-fibrin degradation products.
    Kwaan HC
    Ann Clin Lab Sci; 1980; 10(3):234-7. PubMed ID: 7396389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on the Protocols and Biologic Actions of Platelet Rich Fibrin in Dentistry.
    Shah R; M G T; Thomas R; Mehta DS
    Eur J Prosthodont Restor Dent; 2017 Jun; 25(2):64-72. PubMed ID: 28590091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative histopathological studies of the tissue reactions to metal and bioplast nails implanted into the bone marrow cavity].
    Horváth N; Somogyvári K
    Morphol Igazsagugyi Orv Sz; 1971 Jan; 11(1):59-64. PubMed ID: 5151833
    [No Abstract]   [Full Text] [Related]  

  • 7. [Histological study of the absorption of bioplasts implanted into the bone marrow cavity of tubular bones].
    Somogyvári K; Horváth N
    Morphol Igazsagugyi Orv Sz; 1971 Apr; 11(2):97-102. PubMed ID: 5151925
    [No Abstract]   [Full Text] [Related]  

  • 8. Are there special considerations relevant to trials of biologic agents?
    Strand V
    J Rheumatol Suppl; 1994 Sep; 41():41-5; discussion 45-9. PubMed ID: 7799384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Collagen and fibrin as biologic binders for granular hydroxylapatite].
    Hotz G; Mall G; Born IA; Gilde H
    Dtsch Z Mund Kiefer Gesichtschir; 1989; 13(4):296-300. PubMed ID: 2561550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of chemotherapeutic and bactericidal substances on biologic synthesis of methionine].
    PERSHIN GN; NESVAD'BA VV; SHATILOVA EK
    Biokhimiia; 1953; 18(1):120-3. PubMed ID: 13140383
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of platelet-rich fibrin as an autologous biologic rejuvenating media for avulsed teeth - an in vitro study.
    Hiremath H; Kulkarni S; Sharma R; Hiremath V; Motiwala T
    Dent Traumatol; 2014 Dec; 30(6):442-6. PubMed ID: 24924343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of probiotics as biologic drugs.
    Hoffman FA
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S125-7; discussion S144-51. PubMed ID: 18181717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features.
    Dohan DM; Choukroun J; Diss A; Dohan SL; Dohan AJ; Mouhyi J; Gogly B
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):e45-50. PubMed ID: 16504850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment by defibrination with ancrod in a patient with hyperacute renal allograft failure and a deficiency of plasma prostacyclin stimulating factor.
    Dosekun AK; First MR; Chandran PK; Kant KS; Glas-Greenwalt P; Weiss MA; Alexander JW; Pollak VE
    Clin Nephrol; 1982 Aug; 18(2):101-5. PubMed ID: 6754189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a novel marine natural product: pyrano indolone alkaloid fibrinolytic compound on thrombolysis and hemorrhagic activities in vitro and in vivo.
    Yan T; Wu W; Su T; Chen J; Zhu Q; Zhang C; Wang X; Bao B
    Arch Pharm Res; 2015 Aug; 38(8):1530-40. PubMed ID: 25475097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it possible to withdraw biologics from therapy in rheumatoid arthritis?
    Tanaka Y; Hirata S
    Clin Ther; 2013 Dec; 35(12):2028-35. PubMed ID: 24290736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical methods for assessment of biosimilarity using biomarker data.
    Chow SC; Lu Q; Tse SK; Chi E
    J Biopharm Stat; 2010 Jan; 20(1):90-105. PubMed ID: 20077251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic versus chronologic age.
    BENJAMIN H
    J Gerontol; 1947 Jul; 2(3):217-27. PubMed ID: 20264999
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel.
    Buchta C; Hedrich HC; Macher M; Höcker P; Redl H
    Biomaterials; 2005 Nov; 26(31):6233-41. PubMed ID: 15921738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological behavior of higher molecular weight products of fibrinolysis.
    Chang ML; Bang NU
    J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.